Oct 5
Current report
6-K
Current report
Trinity Biotech plc shareholders approved all resolutions at the September 30, 2026 annual general meeting, including reappointing Grant Thornton, authorizing auditor remuneration and reappointing Dr Andrew Omidvar; approval reached a minimum of 95% of votes cast.